Zobrazeno 1 - 10
of 13
pro vyhledávání: '"David S. Poch"'
Autor:
Emanuel A. Keiler, Kim M. Kerr, David S. Poch, Jenny Z. Yang, Demosthenes G. Papamatheakis, Mona Alotaibi, Angela Bautista, Victor G. Pretorius, Michael M. Madani, Nick H. Kim, Timothy M. Fernandes
Publikováno v:
Pulmonary Circulation, Vol 14, Iss 2, Pp n/a-n/a (2024)
Abstract Current predictors of clinical outcomes after pulmonary thromboendarterectomy (PTE) in patients with chronic thromboembolic pulmonary hypertension (CTEPH) are largely limited to preoperative clinical characteristics. N‐terminal‐pro‐bra
Externí odkaz:
https://doaj.org/article/5ec74f813f3045e987f9b2a069687eed
Publikováno v:
Pulmonary Circulation, Vol 13, Iss 4, Pp n/a-n/a (2023)
Abstract Chronic thromboembolic pulmonary hypertension (CTEPH) is caused by persistent organized thromboembolic obstruction of the pulmonary arteries from incompletely resolved pulmonary embolism. The treatment of choice is pulmonary thromboendartere
Externí odkaz:
https://doaj.org/article/c76824ada7b54539b46d418ae6621ce6
Autor:
David S. Poch, Ehtisham Mahmud, Mitul Patel, Demosthenes Papamatheakis, Timothy Fernandes, Kim Kerr, Jenny Yang, Victor Pretorius, Michael M. Madani, Nick H. Kim
Publikováno v:
Pulmonary Circulation, Vol 12, Iss 4, Pp n/a-n/a (2022)
Abstract Chronic thromboembolic pulmonary hypertension (CTEPH) is the result of incompletely resolved pulmonary emboli (PE) that lead to chronic right heart failure. The two mechanical treatment options are pulmonary thromboendarterectomy (PTE) and b
Externí odkaz:
https://doaj.org/article/4630f1a2df3f4bfcb805c45363cef151
Autor:
Jenny Z. Yang, Mazen F. Odish, Hannah Mathers, Nicole Pebley, Gabriel Wardi, Demosthenes G. Papamatheakis, David S. Poch, Nick H. Kim, Timothy M. Fernandes, Rebecca E. Sell
Publikováno v:
Pulmonary Circulation, Vol 12, Iss 2, Pp n/a-n/a (2022)
Abstract Over the past 20 years, despite significant advancements in pulmonary arterial hypertension (PAH) medical therapy, many patients require admission to the hospital and are at risk for in‐hospital cardiac arrest (IHCA). Prior data found poor
Externí odkaz:
https://doaj.org/article/a57250a4047441f3a07df00ab371b6aa
Publikováno v:
Pulmonary Circulation, Vol 10 (2020)
Externí odkaz:
https://doaj.org/article/b6ef5d268dbe4638ab982eda96477716
Autor:
Timothy M. Fernandes, Nick H. Kim, Kim M. Kerr, William R. Auger, Peter F. Fedullo, David S. Poch, Jenny Yang, Demosthenes G. Papamatheakis, Mona Alotaibi, Marie A. Bautista, Victor G. Pretorius, Michael M. Madani
Publikováno v:
The Journal of Heart and Lung Transplantation.
Autor:
Anna Astashchanka, Kim M. Kerr, Jenny Z. Yang, Angela Bautista, Demosthenes G. Papamatheakis, David S. Poch, Nick H. Kim, Victor G. Pretorius, Michael M. Madani, Timothy M. Fernandes
Publikováno v:
The Journal of Thoracic and Cardiovascular Surgery.
Autor:
Lewis D. Hahn, Demosthenes G. Papamatheakis, Timothy M. Fernandes, David S. Poch, Jenny Yang, Jody Shen, Carl K. Hoh, Albert Hsiao, Kim M. Kerr, Victor Pretorius, Michael M. Madani, Nick H. Kim, Seth J. Kligerman
Publikováno v:
Radiographics : a review publication of the Radiological Society of North America, Inc. 43(2)
Management of chronic thromboembolic pulmonary hypertension (CTEPH) should be determined by a multidisciplinary team, ideally at a specialized CTEPH referral center. Radiologists contribute to this multidisciplinary process by helping to confirm the
Autor:
Alisha A. Kabadi, Timothy M. Fernandes, Demosthenes G. Papamatheakis, David S. Poch, Nick H. Kim, Jenny Z. Yang, Angela Bautista, Victor G. Pretorius, Michael M. Madani, Kim M. Kerr
Publikováno v:
The Annals of Thoracic Surgery.
Airway hemorrhage is a known complication of pulmonary thromboendarterectomy (PTE) in patients with chronic thromboembolic pulmonary hypertension. Predisposing factors for postoperative airway hemorrhage have not been well-described. The aims of this
Autor:
Sheryl Wu, Heather B. Hoang, Jenny Z. Yang, Demosthenes G. Papamatheakis, David S. Poch, Mona Alotaibi, Sandra Lombardi, Cynthia Rodriguez, Nick H. Kim, Timothy M. Fernandes
Publikováno v:
Chest. 162(6)
The management of pulmonary arterial hypertension (PAH) has become more complex in recent years because of increased pharmacotherapy options and longer patient survival with increasing numbers of comorbidities. As such, more opportunities exist for d